Physician profile
Peter Kelly
NPI 1982869467
$6,746.50
in general payments reported to CMS, 2019-2025
10 companies · $344 in 2025
The $344 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,056 · 2020: $2,030 · 2021: $483 · 2022: $1,003 · 2023: $430 · 2024: $400 · 2025: $344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,100 · Food and Beverage: $73.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,100.00 |
| Food and Beverage | $73.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardinal Health 110 LLC | $6,300.00 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $108.75 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $101.85 | 2021-2022 | |
| Novo Nordisk INC | $71.56 | 2019-2022 | |
| Lilly USA, LLC | $48.36 | 2020-2022 | |
| Abbott Laboratories | $43.85 | 2025 | Jot Dx |
| Amarin Pharma, INC. | $29.24 | 2020-2021 | |
| Philips North America LLC | $15.61 | 2023 | |
| Dentsply Sirona INC | $14.24 | 2023 | Cavitron |
| Pharmacyclics LLC, An Abbvie Company | $13.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Kelly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.